Covered recipient · General Payments record
GLENN GORDON HAMM
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2022
$736.84
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $367.33 | 18 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $108.21 | 6 |
| Merck Sharp & Dohme Corporation | $84.46 | 4 |
| Supernus Pharmaceuticals, Inc. | $63.68 | 1 |
| GlaxoSmithKline, LLC. | $46.55 | 3 |
| Seqirus USA Inc | $28.89 | 2 |
| Neurelis, Inc. | $19.50 | 1 |
| PFIZER INC. | $16.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $16.21 | 05/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884495 | CMS |
| Corium, LLC | $13.04 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884497 | CMS |
| Corium, LLC | $17.49 | 07/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884499 | CMS |
| Corium, LLC | $20.97 | 09/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884501 | CMS |
| Corium, LLC | $17.32 | 10/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884503 | CMS |
| Corium, LLC | $23.18 | 12/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924884505 | CMS |
| GlaxoSmithKline, LLC. | $17.32 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944840619 | CMS |
| GlaxoSmithKline, LLC. | $12.88 | 03/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944840617 | CMS |
| GlaxoSmithKline, LLC. | $16.35 | 08/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944840621 | CMS |
| Merck Sharp & Dohme LLC | $23.37 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944328795 | CMS |
| Merck Sharp & Dohme LLC | $21.42 | 07/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944353973 | CMS |
| Merck Sharp & Dohme LLC | $18.52 | 10/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944284367 | CMS |
| Merck Sharp & Dohme LLC | $21.15 | 12/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944290097 | CMS |
| Neurelis, Inc. | $19.50 | 08/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 950150935 | CMS |
| PFIZER INC. | $16.04 | 08/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949248767 | CMS |
| Seqirus USA Inc | $12.59 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 900644085 | CMS |
| Seqirus USA Inc | $16.30 | 10/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 900644115 | CMS |
| Supernus Pharmaceuticals, Inc. | $63.68 | 11/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952968223 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.